Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Shyr

Showing results (351-360 of 435) with videos related to

Pageof 44
Sort By:
The Oncologist|January 17, 2020
Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for ImmunotherapySatya Das, Kristen K Ciombor, Sigurdis Haraldsdottir, et al.
Pediatric Blood & Cancer|November 18, 2014
Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trialNajibah A Galadanci, Shehu U Abdullahi, Musa A Tabari, et al.
American Journal of Respiratory and Critical Care Medicine|September 24, 2005
Proteomic patterns of preinvasive bronchial lesionsS M Jamshedur Rahman, Yu Shyr, Pinar B Yildiz, et al.
Cell|April 3, 2012
The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressorAnne E Powell, Yang Wang, Yina Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2012
Added value of a serum proteomic signature in the diagnostic evaluation of lung nodulesChad V Pecot, Ming Li, Xueqiong J Zhang, et al.
Circulation. Arrhythmia and Electrophysiology|September 27, 2022
A Mechanistic Clinical Trial Using (<i>R</i>)- Versus <i>(S</i>)-Propafenone to Test RyR2 (Ryanodine Receptor) Inhibition for the Prevention of Atrial Fibrillation InductionM Benjamin Shoemaker, Zachary T Yoneda, Diane M Crawford, et al.
JAMA|September 30, 2025
Artificial Intelligence Across the JAMA Network: A Call for SubmissionsT Y Alvin Liu, Yulin Hswen, Robert O Bonow, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 14, 2021
Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for InvestigationChristian Rolfo, Noy Meshulami, Alessandro Russo, et al.
Biochemical Pharmacology|December 7, 2020
Differential immunomodulatory effect of PARP inhibition in BRCA1 deficient and competent tumor cellsIsabel Alvarado-Cruz, Mariam Mahmoud, Mohammed Khan, et al.
JCI Insight|November 25, 2016
The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancerS M Jamshedur Rahman, Xiangming Ji, Lisa J Zimmerman, et al.
Pageof 44

Showing results (351-360 of 435) with videos related to

Sort By:
Pageof 44
The Oncologist|January 17, 2020
Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for ImmunotherapySatya Das, Kristen K Ciombor, Sigurdis Haraldsdottir, et al.
Pediatric Blood & Cancer|November 18, 2014
Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trialNajibah A Galadanci, Shehu U Abdullahi, Musa A Tabari, et al.
American Journal of Respiratory and Critical Care Medicine|September 24, 2005
Proteomic patterns of preinvasive bronchial lesionsS M Jamshedur Rahman, Yu Shyr, Pinar B Yildiz, et al.
Cell|April 3, 2012
The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressorAnne E Powell, Yang Wang, Yina Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2012
Added value of a serum proteomic signature in the diagnostic evaluation of lung nodulesChad V Pecot, Ming Li, Xueqiong J Zhang, et al.
Circulation. Arrhythmia and Electrophysiology|September 27, 2022
A Mechanistic Clinical Trial Using (<i>R</i>)- Versus <i>(S</i>)-Propafenone to Test RyR2 (Ryanodine Receptor) Inhibition for the Prevention of Atrial Fibrillation InductionM Benjamin Shoemaker, Zachary T Yoneda, Diane M Crawford, et al.
JAMA|September 30, 2025
Artificial Intelligence Across the JAMA Network: A Call for SubmissionsT Y Alvin Liu, Yulin Hswen, Robert O Bonow, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 14, 2021
Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for InvestigationChristian Rolfo, Noy Meshulami, Alessandro Russo, et al.
Biochemical Pharmacology|December 7, 2020
Differential immunomodulatory effect of PARP inhibition in BRCA1 deficient and competent tumor cellsIsabel Alvarado-Cruz, Mariam Mahmoud, Mohammed Khan, et al.
JCI Insight|November 25, 2016
The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancerS M Jamshedur Rahman, Xiangming Ji, Lisa J Zimmerman, et al.
Pageof 44